Remembering Mumps

PLoS Pathogens

Volumn 11, Issue 5, 2015, Pages

  Latner, Donald R ^a   Hickman, Carole J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUMPS VACCINE; NEUTRALIZING ANTIBODY; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; 105AD7 ANTIBODY; ANTIIDIOTYPIC ANTIBODY; VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; DISEASE TRANSMISSION; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MUMPS; NONHUMAN; REVIEW; SEROTYPE; VACCINATION; VIRUS GENOME; ANIMAL; IMMUNITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MUMPS VIRUS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; HUMANS; IMMUNITY; MUMPS; MUMPS VIRUS; TREATMENT OUTCOME; VACCINES;

EID: 84930323520     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004791     Document Type: Review

References (23)

1. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580–9. doi: 10.1056/NEJMoa0706589 18403766
2. Plotkin SA, Orenstein WA, Offit PA, Vaccines. 5th ed. Philadelphia, Pa.: Saunders; 2008. xvii, 1725 p.
3. Katz SL, Hinman AR, Summary and conclusions: measles elimination meeting, 16–17 March 2000. J Infect Dis. 2004;189 Suppl 1:S43–7. 15106088
4. Centers for Disease C, Prevention. Elimination of rubella and congenital rubella syndrome—United States, 1969–2004. MMWR Morb Mortal Wkly Rep. 2005;54(11):279–82. 15788995
5. Anderson LJ, Seward JF, Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J. 2008;27(10 Suppl):S75–9. doi: 10.1097/INF.0b013e3181684d8d 18820583
6. Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP, Molecular biology, pathogenesis and pathology of mumps virus. The Journal of pathology. 2015;235(2):242–52. doi: 10.1002/path.4445 25229387
7. Dittrich S, Hahne S, van Lier A, Kohl R, Boot H, Koopmans M, et al. Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine. 2011;29(49):9271–5. doi: 10.1016/j.vaccine.2011.09.072 21983156
8. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis. 2011;204(9):1413–22. doi: 10.1093/infdis/jir526 21933874
9. Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K, Mumps outbreaks in highly vaccinated populations: What makes good even better? Hum Vaccin. 2009;5(7):494–6. 19279405
10. Latner DR, McGrew M, Williams NJ, Sowers SB, Bellini WJ, Hickman CJ, Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol. 2014;21(3):286–97. doi: 10.1128/CVI.00621-13 24371258
11. Latner DR, McGrew M, Williams N, Lowe L, Werman R, Warnock E, et al. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin Vaccine Immunol. 2011;18(1):35–42. doi: 10.1128/CVI.00284-10 21047998
12. Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, et al. Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice. Immunology. 2010;131(1):33–9. doi: 10.1111/j.1365-2567.2010.03263.x 20586811
13. Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87(22):217–24. 24340404
14. Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012;86(1):615–20. doi: 10.1128/JVI.06125-11 22072778
15. Rubin S, Mauldin J, Chumakov K, Vanderzanden J, Iskow R, Carbone K, Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine. 2006;24(14):2662–8. 16309801
16. Weibel RE, Buynak EB, McLean AA, Roehm RR, Hilleman MR, Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines. Proc Soc Exp Biol Med. 1980;165(2):260–3. 7443713
17. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med. 2012;367(18):1704–13. doi: 10.1056/NEJMoa1202865 23113481
18. McClean HQH C.J., Seward J.F., The Immunological Basis for Immunization Series, Module 16: Mumps. Geneva: World Health Organization; 2010. 44 p.
19. Nelson GE, Aguon A, Valencia E, Oliva R, Guerrero ML, Reyes R, et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of measles-mumps-rubella vaccine for outbreak control—Guam 2009 to 2010. Pediatr Infect Dis J. 2013;32(4):374–80. doi: 10.1097/INF.0b013e318279f593 23099425
20. Fiebelkorn AP, Lawler J, Curns AT, Brandeburg C, Wallace GS, Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA. Emerg Infect Dis. 2013;19(9):1411–7. doi: 10.3201/eid1909.130299 23965729
21. Yoshida N, Fujino M, Miyata A, Nagai T, Kamada M, Sakiyama H, et al. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J Med Virol. 2008;80(3):517–23. doi: 10.1002/jmv.21106 18205215
22. Plotkin SA, Commentary: Mumps vaccines: do we need a new one? Pediatr Infect Dis J. 2013;32(4):381–2. doi: 10.1097/INF.0b013e3182809dda 23552675
23. Xu P, Huang Z, Gao X, Michel FJ, Hirsch G, Hogan RJ, et al. Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate. J Virol. 2013;87(14):8158–68. doi: 10.1128/JVI.01028-13 23678169